Competitive Mirror Image Phage Display Derived Peptide Modulates Amyloid Beta Aggregation and Toxicity

Area of Science:

• Neuroscience
• Biochemistry
• Drug Discovery

Background:

• Alzheimer's disease is the leading cause of dementia with no cure.
• Oligomeric amyloid beta (Aβ) species are implicated as the most neurotoxic forms.
• Aβ monomers may possess neuroprotective functions, contrasting with toxic oligomers.

Purpose of the Study:

• To identify peptides that preferentially bind and stabilize Aβ monomers.
• To develop a method for eliminating toxic Aβ oligomer species.
• To investigate the therapeutic potential of monomer-specific peptides in Alzheimer's disease.

Main Methods:

• Utilized a competitive mirror image phage display to discover Aβ monomer-binding peptides.
• Characterized the identified peptide, Mosd1 (monomer specific d-peptide 1).
• Assessed Mosd1's effect on Aβ1-42 species, cellular toxicity, and neuronal phenotype.

Main Results:

• Mosd1 selectively binds and stabilizes Aβ1-42 monomers.
• Mosd1 effectively removed toxic oligomers from Aβ1-42 mixtures.
• Reduced Aβ1-42-induced toxicity in cell cultures.
• Restored normal physiological phenotype in neuronal cells expressing human amyloid precursor protein.

Conclusions:

• Monomer-specific peptides like Mosd1 can neutralize toxic Aβ oligomers.
• This strategy represents a promising therapeutic avenue for Alzheimer's disease.
• Stabilizing Aβ monomers may counteract the neurotoxic effects of oligomers.